Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,358 | -15,309 | -3,485 | -22,727 | -8,368 |
| Depreciation Amortization | 1,075 | 751 | 1,443 | -1,569 | -1,525 |
| Income taxes - deferred | N/A | N/A | N/A | 831 | N/A |
| Accounts receivable | 1,145 | -1,683 | 1,856 | 592 | 120 |
| Other Working Capital | 292 | -2,514 | 58 | 604 | 2,500 |
| Other Operating Activity | -627 | 4,187 | -2,454 | 8,589 | -1,308 |
| Operating Cash Flow | $-8,473 | $-14,568 | $-2,582 | $-13,680 | $-8,581 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -462 | -1,161 | -722 | -11 | -29 |
| Net Acquisitions | N/A | 26,037 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -609 |
| Other Investing Activity | 4 | 207 | -8 | -1 | -629 |
| Investing Cash Flow | $-458 | $25,083 | $-730 | $-12 | $-658 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 13 | N/A | 54,287 |
| Other Financing Activity | -407 | -588 | -370 | -118 | -3,250 |
| Financing Cash Flow | $-407 | $-588 | $-357 | $-118 | $51,037 |
| Exchange Rate Effect | 252 | -212 | 157 | -879 | -769 |
| Beginning Cash Position | 16,393 | 6,678 | 10,190 | 65,300 | 24,271 |
| End Cash Position | 7,307 | 16,393 | 6,678 | 50,611 | 65,300 |
| Net Cash Flow | $-9,086 | $9,715 | $-3,512 | $-14,689 | $41,029 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,473 | -14,568 | -2,582 | -13,680 | -8,581 |
| Capital Expenditure | -706 | -1,161 | -722 | -11 | -30 |
| Free Cash Flow | -9,179 | -15,729 | -3,304 | -13,691 | -8,611 |